Adherium has announced that Monaghan Medical is set to begin a pilot program to launch Adherium’s Hailie inhaler monitoring platform in eight US respiratory centers by the end of the first quarter of 2021, with more centers expected to be added later in the year. The companies announced their partnership in April 2020 and now say that they have completed training and feasibility testing activities necessary to move ahead.
Adherium CEO Mike Motion said, “This is an important step for Adherium with our Hailie platform and sensors placed with customers and fully supported by Monaghan’s professional sales and clinical team. We have worked closely with Monaghan and adapted our training programs, systems, and support materials to meet patient needs and ensure alignment to Monaghan’s operational model. Our technology will secure recurring revenue from sensor sales and data access which will enable Adherium with Monaghan to commercially address patients who are difficult to treat Asthmatics and late stage COPD patients of which there are more than 8 million in the US alone. We are delighted to be working with Monaghan at this critical time for respiratory healthcare delivery and see their commercial support being highly complementary to the disease management activity provided by our partner HGE.”
Trudell Medical CEO and Monaghan Medical President Gerald Slemko commented, “This milestone reaffirms not just our partnership with Adherium, but also our mission to provide the finest, most researched and innovative products to the respiratory community. In bringing this extended offering to our customers, we continue to build the Monaghan brand and further establish our position as market leaders.”
Monaghan Medical VP Sales and Marketing William Seitz said, “The addition of Adherium’s Hailie technology to our existing portfolio provides our highly experienced sales team with an additional opportunity to engage with customers and offer a digital respiratory solution at a time when remotely managing patients is more critical than ever. This phased introduction will involve truly engaging with our customers to enable Monaghan to continue to deliver value to providers, payers and patients across the US.”
Read the Adherium press release.
